408 related articles for article (PubMed ID: 33905426)
1. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
[TBL] [Abstract][Full Text] [Related]
3. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
[TBL] [Abstract][Full Text] [Related]
4. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis D: A Review.
Negro F; Lok AS
JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
Gheorghe L; Csiki IE; Iacob S; Gheorghe C; Trifan A; Grigorescu M; Motoc A; Suceveanu A; Curescu M; Caruntu F; Sporea I; Brisc C; Rogoveanu I; Cerban R; Tugui L; Alexandrescu A
J Gastrointestin Liver Dis; 2015 Dec; 24(4):413-21. PubMed ID: 26697566
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
8. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
Ji J; Sundquist K; Sundquist J
J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider.
Bahcecioglu IH; Aygun C; Gozel N; Poyrazoglu OK; Bulut Y; Yalniz M
J Viral Hepat; 2011 Jul; 18(7):518-24. PubMed ID: 20546500
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
[TBL] [Abstract][Full Text] [Related]
11. [Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances].
Romeo R
Recenti Prog Med; 2010 Feb; 101(2):52-6. PubMed ID: 20433000
[TBL] [Abstract][Full Text] [Related]
12. Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
Jang TY; Wei YJ; Liu TW; Yeh ML; Liu SF; Hsu CT; Hsu PY; Lin YH; Liang PC; Hsieh MH; Ko YM; Tsai YS; Chen KY; Lin CC; Tsai PC; Wang SC; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Huang CF; Yu ML
Sci Rep; 2021 Apr; 11(1):8184. PubMed ID: 33854160
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
[TBL] [Abstract][Full Text] [Related]
14. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).
Wranke A; Pinheiro Borzacov LM; Parana R; Lobato C; Hamid S; Ceausu E; Dalekos GN; Rizzetto M; Turcanu A; Niro GA; Lubna F; Abbas M; Ingiliz P; Buti M; Ferenci P; Vanwolleghem T; Hayden T; Dashdorj N; Motoc A; Cornberg M; Abbas Z; Yurdaydin C; Manns MP; Wedemeyer H; Hardtke S;
Liver Int; 2018 May; 38(5):842-850. PubMed ID: 28963781
[TBL] [Abstract][Full Text] [Related]
15. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation.
Baskiran A; Akbulut S; Sahin TT; Koc C; Karakas S; Ince V; Yurdaydin C; Yilmaz S
Hepatol Int; 2020 Sep; 14(5):869-880. PubMed ID: 32895876
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of hepatitis D.
Farci P; Niro GA
Semin Liver Dis; 2012 Aug; 32(3):228-36. PubMed ID: 22932971
[TBL] [Abstract][Full Text] [Related]
18. [Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region].
Isaeva OV; Il'chenko LY; Saryglar AA; Karlsen AA; Kyuregyan KK; Mikhailov MI
Vopr Virusol; 2021 Mar; 66(1):74-83. PubMed ID: 33683068
[TBL] [Abstract][Full Text] [Related]
19. The medical impact of hepatitis D virus infection in Uzbekistan.
Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
[TBL] [Abstract][Full Text] [Related]
20. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
